Search


	Podcast:		Cell & Gene: The Podcast
	Episode:		CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant
	Category:		Science & Medicine
	Duration:		00:18:51
	Publish Date:		2024-05-09 08:00:00
	Description:		Dr. Marcus Conant is CMO at Addimmune, a biotech startup developing a cell therapy for HIV that spun out of cell and gene therapy biotech American Gene Technologies (AGT). He spent his career on the front lines of HIV treatment and research and remains an advocate for the HIV patient. He formed the Kaposi’s Sarcoma Research & Education Foundation in 1982, which later became the San Francisco AIDS Foundation. On this episode, Dr. Conant shares they why behind cell and gene therapy to treat HIV, and he explains Addimmune’s lead asset, AGT103-T, which is designed to provide broad protection using silencing RNA to inhibit binding/entry of the virus, halt replication, and prevent escape.
	Total Play:		0